Point72 Asset Management, L.P.
Position in TVTX — Travere Therapeutics, Inc.
CIK 1603466
STAMFORD, CT
Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,204,036
+$20,579,072 QoQ
Shares Held
478,860
+176.2% QoQ
Ownership
0.508%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#39
of 317 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Derivatives in TVTX
reported options exposure · as of Dec 31, 2025CallValue
$462,341
CallShares
12,100
PutValue
$38,909,243
PutShares
1,018,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. TVTX ranks #26 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in TVTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,204,036 | 478,860 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $6,624,964 | 173,383 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $462,341 | 12,100 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $38,909,243 | 1,018,300 | Put | Defined | 2026-02-17 | |
| 2025-06-30 | $2,484,860 | 167,896 | Shares | Defined | 2025-08-14 | |
| 2024-06-30 | $2,635,167 | 320,580 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $6,723,891 | 872,100 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $6,230,286 | 696,900 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $121,333 | 13,572 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $27,432,637 | 1,785,979 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $8,074,675 | 327,706 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $858,141 | 33,300 | Shares | Defined | 2022-05-16 | |
| 2021-03-31 | $40,154,906 | 1,608,126 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $16,925,355 | 621,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 RTRX | — | 1,041,405 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 RTRX | — | 386,126 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 RTRX | — | 303,380 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||